---
category: news
title: "A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation Sequencing (NGS) to Identify GI Cancer Patients for Future Tmod™ CAR T Therapy"
excerpt: "A2 Biotherapeutics, Inc. (“A2 Bio”) is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell therapy platform to tackle the fundamental challenge in solid tumor treatment—the ability of cancer medicines to distinguish between tumor and normal cells."
publishedDateTime: 2022-01-18T22:02:00Z
originalUrl: "https://apnews.com/press-release/BusinessWire/technology-health-business-tumors-cancer-0a96daf42067443faf1d277e845e60dd"
webUrl: "https://apnews.com/press-release/BusinessWire/technology-health-business-tumors-cancer-0a96daf42067443faf1d277e845e60dd"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "iYGOySY4ExoLwsQjyj4/uysVB7jqlWnLFkqO7L7FlH8azAtcFzS4DDyja/pshpOSfUNhkfpyWBmWTY11POXv1uUzMxGKV/NJysD4JInjYwXsA83r0tBkQ0q7pj6nrJI1379GP6plwWkmUiiN8Mqxavz6ge3hJNOXIGGgiKT2wQPL458mr1SOG6sF3BBgFCXwAL7NJ/6vnkB5JJxqI9OK2A+miD/V3ubLRdqoqmG1E9XAd0y0m8FLi7aRiwxUMyP0LV7ampCAxgYdVxtnjyUsPLCnJSplSo6tLYD8wbcWgT0YjAYA66NkW99YKgVJQ0sqnnz+fF3gEePBgOJRMYGw2SEiTyowh1TW05S3CS0wD80=;SPFpW1e5pOx84eSwMYMKWA=="
---

